Cargando…
Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia
Publicly funded healthcare systems, including those in Canada, the United Kingdom (UK), and Australia, often use health technology assessment (HTA) to inform drug reimbursement decision-making, based on dossiers submitted by manufacturers, and HTA agencies issue publicly available reports to support...
Autores principales: | Ball, Graeme, Levine, Mitchell A. H., Thabane, Lehana, Tarride, Jean-Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600934/ https://www.ncbi.nlm.nih.gov/pubmed/36290879 http://dx.doi.org/10.3390/curroncol29100602 |
Ejemplares similares
-
Health Technology Reassessment: Addressing Uncertainty in Economic Evaluations of Oncology Drugs at Time of Reimbursement Using Long-Term Clinical Trial Data
por: Ball, Graeme, et al.
Publicado: (2023) -
Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology
por: Ball, Graeme, et al.
Publicado: (2021) -
Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency
por: Dekker, Marieke J. H. J., et al.
Publicado: (2021) -
Safety of cassia gum as a feed additive for dogs and cats based on a dossier submitted by Intercolloid (UK) Ltd
por: Rychen, Guido, et al.
Publicado: (2017) -
Dosfilos, dossier /
Publicado: (1989)